What is Prevest Denpro Ltd (543363) share price return in the past 10 years?

Data is not available for this company

What is the share price of Prevest Denpro Ltd (543363)?

Company share prices are keep on changing according to the market conditions. The current trading price of Prevest Denpro Ltd (543363) on 02-Sep-2026 16:59:59 at 16:59 is 389.50.

What is the P/E ratio of Prevest Denpro?

The latest standalone P/E ratio of Prevest Denpro as of 02-Sep-2026 is 20.72.

What is the P/B ratio of Prevest Denpro Ltd (543363)?

The latest standalone P/B ratio of Prevest Denpro Ltd (543363) as of 02-Sep-2026 is 3.55.

What is the 52-week high and low of Prevest Denpro Ltd (543363)?

The 52-week high of Prevest Denpro Ltd (543363) is Rs. 605.00 and the 52-week low is Rs. 318.15.

Prevest Denpro Ltd (543363)

Name: Prevest Denpro Ltd (543363)
Brand: Prevest Denpro

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543363 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Prevest Denpro Share Price

₹389.50 5.95 (1.55%)

As on 02-Sep'26 16:59

Prevest Denpro Ltd (543363)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543363 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Prevest Denpro Share Price

₹389.50 5.95 (1.55%)

As on 02-Sep'26 16:59

Key Metrics

Valuation Multiples

Market Cap

₹468 Cr.

Current Price

₹389.5

52-Week Low / High

₹318 / 605

TTM EPS

₹18.8

TTM Sales

₹75.4 Cr.

Book Value per Share

₹109.6

P/E Ratio

20.72

Lower than its 5-year historical median

Industry PE

124.7

Price to Book (P/B)

3.55

Lower than its 5-year historical median

Price to Sales (P/S)

6.20

Lower than its 5-year historical median

EV/EBITDA

12.32

Lower than its 5-year historical median

Dividend Yield

0.26%

Profitability Efficiency

Return on Equity (ROE)

18.51%

Outperforms industry median

Return on Capital Employed (ROCE)

24.90%

Outperforms industry median

Return on Assets (ROA)

17.35%

Operating Profit Margin

36%

Net Profit Margin

29.89%

Gross Profit Margin

41.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

13.62%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

15.64%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

17.69%

Asset Quality

Promoter Holding

73.60%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹120 Cr.

Equity

₹12 Cr.

Face Value

₹10

All Time Low / High

₹170.65 / 686.00

Prevest Denpro stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Undervalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Prevest Denpro Ltd a good quality company?

Prevest Denpro Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Prevest Denpro Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Prevest Denpro Ltd vs industry peers?

Prevest Denpro Ltd revenue CAGR is 20.27%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Prevest Denpro Ltd?

Promoters hold 73.60% of the Prevest Denpro Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Prevest Denpro Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -7.68% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	0%	37.2%	39.3%	45.6%	47%	39.6%	32.3%	26.8%	25.3%	24.9%	-
Value Creation Index ⓘ	NA	1.7	1.8	2.3	2.4	1.8	1.3	0.9	0.8	0.8	-
Growth Parameters ⓘ
Sales ⓘ	0	17	19.3	22.8	28.5	38.1	49.9	56.4	63.1	71.7	75
Sales YoY Gr.	-	NA	13.6%	18.1%	25.1%	33.8%	30.8%	13.2%	11.8%	13.6%	-
Adj EPS ⓘ	0	2.4	3.3	5.6	8	9.5	12.9	13.2	15	17.6	18.8
YoY Gr.	-	NA	39.5%	68.4%	43.1%	18.3%	35.8%	3%	13.1%	17.2%	-
BVPS (₹) ⓘ	0	8.3	11.7	17.3	25.5	47.6	60.7	73.8	88	104.8	109.6
Adj Net Profit ⓘ	0	2.1	2.9	4.9	7.1	11.4	15.4	15.9	18	21.1	23
Cash Flow from Ops. ⓘ	0	2.4	3	4.7	8.8	7	10.4	11.5	15	15.9	-
Debt/CF from Ops. ⓘ	0	0.5	0.5	0.4	0.2	0.2	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	20.3%	12.9%	13.6%
Adj EPS ⓘ	NA	17%	11%	17.2%
BVPSⓘ	NA	32.7%	20%	19.2%
Share Price	-	-	-7.3%	-33.1%

Key Financial Parameters ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	28.8	33.3	38.6	37.4	28.6	23.8	19.7	18.5	18.2	17.5
Op. Profit Mgn % ⓘ	18	20.1	22.8	31.7	39.9	39.7	35.5	35.4	36	35.7
Net Profit Mgn % ⓘ	12.4	15.2	21.7	24.8	29.8	31	28.2	28.5	29.4	29.9
Debt to Equity ⓘ	0.2	0.1	0.1	0.1	0	0	0	0	0	-
Working Cap Days ⓘ	0	69	74	75	76	85	100	107	114	242
Cash Conv. Cycle ⓘ	0	14	19	-4	-2	32	58	70	69	226

Valuation of Prevest Denpro - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	17	19	23	28	38	50	56	63	72
Operating Expenses ⓘ +	14	15	18	19	23	30	36	41	46
Manufacturing Costs	1	1	1	0	0	0	1	1	1
Material Costs	5	6	7	8	10	13	14	14	17
Employee Cost	3	3	5	3	4	5	6	6	7
Other Costs ⓘ	5	5	5	8	9	12	16	20	21
Operating Profit ⓘ	3	4	5	9	15	20	20	22	26
Operating Profit Margin (%)	17.4%	20.1%	22.8%	31.7%	39.9%	39.7%	35.5%	35.4%	36.0%
Other Income ⓘ +	1	0	2	1	2	2	3	4	5
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	1	1	1	2	2
Profit Before Tax ⓘ	3	4	6	9	16	21	21	24	29
Tax ⓘ	1	1	1	2	4	5	5	6	7
Profit After Tax	2	3	5	7	12	16	16	18	21
PAT Margin (%)	12.8%	15.5%	22.0%	25.3%	30.4%	31.5%	28.6%	28.9%	29.9%
Adjusted EPS (₹)	2.5	3.4	5.7	8.2	9.6	13.1	13.4	15.2	17.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	7.60%	7.40%	6.60%	5.60%

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	7	10	15	22	57	73	89	106	126
Share Capital ⓘ	0	0	0	0	12	12	12	12	12
Reserves ⓘ	7	10	15	22	45	61	77	94	114
Debt +	1	1	2	1	1	0	0	0	0
Long Term Debt	1	1	2	1	1	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
Trade Payables	1	1	1	4	2	1	1	2	2
Others Liabilities ⓘ	2	2	3	3	4	4	5	5	6
Total Liabilities ⓘ	11	15	21	31	64	79	95	113	134
Fixed Assets
Net Fixed Assets ⓘ +	4	5	5	5	7	7	27	27	27
Gross Block	6	8	8	9	11	12	33	35	36
Accumulated Depreciation	2	3	3	4	4	5	6	8	10
CWIP ⓘ	0	0	0	2	5	17	0	0	0
Investments ⓘ	0	0	0	0	1	1	2	5	9
Inventories	0	0	1	1	3	5	6	8	11
Trade Receivables	2	2	2	4	2	4	8	8	9
Cash Equivalents ⓘ	4	6	10	16	42	39	48	60	73
Others Assets ⓘ	1	1	2	2	4	5	4	5	6
Total Assets ⓘ	11	15	21	31	64	79	95	113	134

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	2	3	5	9	7	10	11	15	16
PBT ⓘ	3	4	6	9	16	21	21	24	29
Adjustment ⓘ	1	0	0	0	-1	-1	-1	-2	-2
Changes in Working Capital ⓘ	-1	-0	-1	1	-4	-4	-4	-1	-4
Tax Paid ⓘ	-1	-1	-1	-2	-4	-5	-5	-6	-6
Cash Flow From Investing Activity ⓘ +	-1	-1	-1	-2	-4	-12	-2	-2	-2
Capex	-1	-1	-1	-2	-5	-14	-4	-2	-2
Net Investments	0	-0	-0	-0	-0	-0	-1	-3	-5
Others ⓘ	0	0	0	1	1	2	2	4	4
Cash Flow From Financing Activity ⓘ +	-0	0	0	-1	23	-1	-0	-1	-1
Net Proceeds from Shares ⓘ	0	0	0	0	23	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0	0	0	-0	-0	-1	0	0	0
Interest Paid ⓘ	-0	-0	-0	-0	-0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	-0	-1	-1
Others ⓘ	0	-0	0	-0	0	0	0	0	0
Net Cash Flow ⓘ	1	2	4	6	26	-3	9	12	12

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	29.72	34.02	39.13	38.13	29.07	24.19	19.98	18.74	18.51
ROCE (%)	37.15	39.27	45.63	46.96	39.64	32.25	26.8	25.26	24.9
Asset Turnover Ratio	1.54	1.49	1.28	1.12	0.83	0.71	0.67	0.63	0.6
PAT to CFO Conversion(x)	1	1	1	1.29	0.58	0.63	0.69	0.83	0.76
Working Capital Days
Receivable Days	31.80	36.60	36.10	37.10	28.10	23.80	38.90	44.90	41.20
Inventory Days	10	9	12.80	15.10	21	29	34.30	39.60	46.20
Payable Days	71.60	64.30	68.70	122.30	104.60	43.90	35.20	38.30	44.30

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Prevest Denpro Ltd FAQs

The current trading price of Prevest Denpro on 02-Sep-2026 16:59 is ₹389.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Sep-2026 the market cap of Prevest Denpro stood at ₹467.5 Cr

The latest P/E ratio of Prevest Denpro as of 01-Sep-2026 is 20.72.

The latest P/B ratio of Prevest Denpro as of 01-Sep-2026 is 3.55.

The 52-week high of Prevest Denpro is ₹605.0 and the 52-week low is ₹318.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Prevest Denpro is ₹75.39 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Prevest Denpro Ltd is a good quality company.

The key valuation ratios of Prevest Denpro Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Prevest Denpro Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Prevest Denpro Ltd

The company develops, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The breadth and depth of its product offerings address majority of the dentists’ clinical needs for consumable dental materials. Its product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables. Its products are sold in the regions of Europe, Asia, South America, Middle East and Africa. Further, as per its diversification plans, the company is currently expanding its existing manufacturing unit by setting up another manufacturing facility for manufacturing new line of products that will include hygiene products (sanitizers and disinfectants), oral hygiene products (mouth washes and mouth rinses), oral care products(medicated ointments, gels and creams for dental treatment) and biomaterials (i.e. bone augmentation materials). The proposed facility will be well-equipped with latest machineries.

Business area of the company

The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.

Key events and milestones

1999: Incorporation of the Company.
2000: First Manufacturing unit was established at Digiana, Jammu, J&K.
2011: Second Manufacturing unit was established at Samba, J&K.
2014-15: Crossed Turnover of Rs 10 crore.
2016: Won Sushruta award for Best Dental Manufacture by the Indian Dental Association’s.
2016: Received Certificate for ‘Best Enterprise’ in the field of manufacture of dental materials, India by the Socrates Committee, Oxford, UK.
2017: Shifted manufacturing operations from First Manufacturing Unit to Second Manufacturing unit.
2017: Won “Northern Region Export Excellence Award” - Gold Trophy for outstanding export performance in the category of top exporter J&K - SME by FIEO (2017).
2019-20: Crossed Turnover of Rs 20 crore.

You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Prevest Denpro Ltd (543363)

Prevest Denpro Ltd (543363)

Prevest Denpro stock performance